Heidi Steinfeldt
- Molecular Biology top 10%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Steven D. ReichGeorge WildingYazdi K. PithavalaRoy S. HerbstHope S. RugoJohn W. ParkGlenn LiuMerrill S. Kies
- Topics
- Angiogenesis and VEGF in Cancer (5 papers)Renal cell carcinoma treatment (3 papers)Cancer therapeutics and mechanisms (2 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Heidi Steinfeldt
10 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 694
- Oncology 586
- Pulmonary and Respiratory Medicine 401
- Cancer Research 254
- Radiology, Nuclear Medicine and Imaging 128
Countries citing papers authored by Heidi Steinfeldt
This map shows the geographic impact of Heidi Steinfeldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Steinfeldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Steinfeldt more than expected).
Fields of papers citing papers by Heidi Steinfeldt
This network shows the impact of papers produced by Heidi Steinfeldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Steinfeldt. The network helps show where Heidi Steinfeldt may publish in the future.
Co-authorship network of co-authors of Heidi Steinfeldt
This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Steinfeldt. A scholar is included among the top collaborators of Heidi Steinfeldt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Steinfeldt. Heidi Steinfeldt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 298 | |
| 2 | A phase I trial of the heat shock protein 90 (HSP90) inhibitor alvespimycin (17-dimethylaminoethylamino-17-demethoxygeldanamycin 17-DMAG) administered weekly, intravenously, to patients with advanced, solid tumors | 2 |
| 3 | 38 | |
| 4 | 37 | |
| 5 | 410 | |
| 6 | 202 | |
| 7 | 112 | |
| 8 | 13 | |
| 9 | 4 | |
| 10 | 15 |
About Heidi Steinfeldt
Heidi Steinfeldt is a scholar working on Hepatology, Hematology and Molecular Biology, having authored 10 papers that have together received 1.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (5 papers), Renal cell carcinoma treatment (3 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Oncology (586 citations), Cancer Research (254 citations) and Pulmonary and Respiratory Medicine (401 citations). Heidi Steinfeldt has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Steven D. Reich, George Wilding, Yazdi K. Pithavala, Roy S. Herbst, Hope S. Rugo, John W. Park, Glenn Liu, Merrill S. Kies, James L. Freddo and Christopher J. Jones. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.